Eclipsys Increases KLAS Rankings with Debut of Integrated Pharmacy Solution at No. 4

Eclipsys Corporation^®, (NASDAQ:ECLP), The Outcomes Company^®, today announced that the company’s focus on delivering an enterprise portfolio of high-quality health information software solutions is reflected in the findings of the 2009 "Top 20 Best in KLAS Award: Software and Professional Services” report (2009 Top 20 Best in KLAS Awards report). With a national spotlight on adoption of electronic medical records (EMRs), Eclipsys’ acute care EMR repeated its No. 2 ranking in its category, while the company’s integrated pharmacy solution debuted in the No. 4 spot within its segment. In addition, for the fourth straight year, Eclipsys’ integrated performance management solution, Sunrise EPSi™, received top honors in the Decision Support-Business market segment with a "Best in KLAS” award, and its Budgeting software was named a category leader for the third straight year.

"We are honored to continue to be named number one by our clients as reported by KLAS," said Tim Rutledge, Eclipsys’ senior vice president of Enterprise Performance Management. "We remain focused on providing healthcare organizations with effective and efficient tools to build in best practices and help them in achieving their business goals. It is abundantly gratifying to continue to grow in market share while attaining distinguished client satisfaction awards.”

Company’s Enterprise Portfolio Reflected in Software Solution Rankings

Findings of the KLAS report also state that:

• Eclipsys’ Sunrise Clinical Manager^TM once again ranked No. 2 in the Acute Care EMR market segment. In 2008, Eclipsys moved up to the second spot in this category. According to the KLAS CPOE Digest 2009: Meaningful Use and Physician Adoption report, deep adoption is pivotal to the overarching success of an EMR implementation. The same KLAS report concludes that Eclipsys leads the industry in total physicians live on computerized physician order entry (CPOE) and percentage of its client base using the system.
• Eclipsys’ pharmacy solution, Sunrise Pharmacy™, which was introduced to the market only three years ago, debuted with a No. 4 ranking in its category. With the second highest percentage among the eight vendors qualified to be ranked in the pharmacy segment, 89 percent of Eclipsys clients would buy the integrated pharmacy solution again.
• Eclipsys Sunrise Patient Financials™ saw the biggest year-over-year increase among fully-rated products in the Patient Accounting segment.

"Our software solution rankings reflect our company’s growth and maturity into a leading enterprise vendor of healthcare information technology,” said Jay Deady, Eclipsys’ executive vice president of Client Solutions. "Eclipsys offers a truly integrated clinical system, along with the highest CPOE adoption by physicians. Those distinctions, in combination with our second place EMR and a client base that outperforms the industry in composite performance across all CMS Quality Measures are clear proof points of our differentiating ability to help support providers in meeting the expected "meaningful use” objectives of the American Recovery and Reinvestment Act (ARRA) of 2009.”

Meeting the Medication Management Component of ARRA

The superior integration of Eclipsys’ pharmacy solution with its marketing-leading CPOE system is expected to be a significant factor in helping hospitals to meet the medication management component of ARRA. The safety and workflow benefits derived from combining the two solutions have resulted in strong client adoption and satisfaction. The number of live Eclipsys pharmacy client sites doubled in 2008, with that number projected to increase by another 65 percent at the close of 2009. More than 80 percent of Eclipsys pharmacy clients also utilize the company’s CPOE solution. Among these pharmacy clients, 75 percent have achieved a 50 percent or higher CPOE adoption rate.

A Client Base Ranked No. 1 in Meeting Composite CMS Quality Measures; Dominates Magnet Hospitals

In conducting a competitive analysis study of CMS Core Measures performance, data identified Eclipsys clients as ranking No. 1 in composite performance across all Centers for Medicare and Medicaid (CMS) Quality Measures. The study, which was based on data from HIMSS Analytics and the U.S. Department of Health and Human Services Hospital Compare site, also identified that Eclipsys clients ranked No. 1 in adherence to surgery CMS criteria, while statistically tying in adherence to heart failure, acute myocardial infarction (AMI) and pneumonia. In addition, Eclipsys clinical information systems are used by 45 percent of the Magnet Recognition Program® hospitals, and Eclipsys clients represent 40 percent of the facilities that the U.S. News and World Report ranked among "America’s Best Hospitals” in 2009.

About the 2009 Top 20 Best in KLAS Awards: Software and Professional Services report

The report reflects the summary of healthcare information technology (HIT) software and professional services performance data as reported by physician offices, clinics, IDNs, inpatient facilities, and applicable healthcare agencies. The HIT software ratings reflect data collected over the past 12 months (October 15, 2008 – November 15, 2009); the professional services ratings reflect data collected over the past 18 months (May 15, 2008 – November 15, 2009). Each product or segment is listed by market segment.

About the KLAS CPOE Digest 2009

The KLAS CPOE Digest 2009 compiled data from healthcare executives, managers and clinicians. The study provided detailed information on several criteria including current CPOE usage at healthcare organizations, product capabilities and vendor performance.

About KLAS

KLAS is a research firm specializing in monitoring and reporting the performance of healthcare vendors. KLAS' mission is to improve delivery, by independently measuring vendor performance for the benefit of its healthcare provider partners, consultants, investors, and vendors. Working together with executives from over 4500 hospitals and over 2500 clinics, KLAS delivers timely reports, trends, and statistics, which provide a solid overview of vendor performance in the industry. KLAS measures performance of software, professional services, and medical equipment vendors. For more information, go to www.KLASresearch.com , or email marketing@KLASresearch.com , or call 1-800-920-4109 to speak with a KLAS representative.

About the Magnet Recognition Program

The Magnet Recognition Program® was developed by the American Nurses Credentialing Center (ANNC) to recognize healthcare organizations that provide nursing excellence. The program also provides a vehicle for disseminating successful nursing practices and strategies. Recognizing quality patient care, nursing excellence and innovations in professional nursing practice, the Magnet Recognition Program provides consumers with the ultimate benchmark to measure the quality of care that they can expect to receive. For more information, go to www.nursingcredentialing.com.

About What is Meaningful

The American Recovery and Reinvestment Act and its HITECH provision have set the industry on a quest for answers to many questions. Eclipsys is sponsoring a new web site to solicit opinions on these questions. The site, www.whatismeaningful.com, was created to promote, educate and provide a valuable resource that informs and delivers best practices. This web site will go beyond the government definitions of meaningful use and explore how providers can drive improved outcomes through the use of healthcare information technology. Visit this web site to keep informed of the latest information being shared about ARRA.

About Eclipsys

Eclipsys is a leading provider of advanced integrated clinical, revenue cycle and performance management software, clinical content and professional services that help healthcare organizations improve clinical, financial and operational outcomes. For more information, see www.eclipsys.com or email info@eclipsys.com.

Forward-looking Statements

Statements in this news release concerning the timing of implementation and features and benefits provided by Eclipsys software, ARRA qualification, evidence-based content and implementation services are forward-looking statements and actual results may differ from those projected due to a variety of risks and uncertainties. Implementation and customization of Eclipsys software is complex and time-consuming. Results depend upon a variety of factors and can vary by client. Each client’s circumstances are unique and may include unforeseen issues that make it more difficult than anticipated to implement or derive benefit from Eclipsys software or services. The success and timeliness of the company’s services will depend at least in part upon client involvement, which can be difficult to control. Eclipsys is required to meet specified performance standards, and the contract can be terminated or its scope reduced under certain circumstances. ARRA qualification requires compliance with standards that are still evolving, and satisfaction of those standards may be delayed. More information about company risks is available in recent Form 10-Q and 10-K filings made by Eclipsys from time to time with the Securities and Exchange Commission. Special attention is directed to the portions of those documents entitled "Risk Factors” and "Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Eclipsys Corporation and The Outcomes Company are registered trademarks of Eclipsys Corporation. Sunrise EPSi, Sunrise Clinical Manager, Sunrise Pharmacy and Sunrise Patient Financials are trademarks of Eclipsys Corporation. Other product and company names in this news release are or may be trademarks and/or registered trademarks of their respective companies.